首页500124 • BOM
add
瑞迪制药
昨日收盘价
₹1,200.50
当日价格范围
₹1,188.65 - ₹1,210.40
年度波幅
₹1,074.35 - ₹1,420.20
市值
9932.37亿 INR
平均交易量
5.88万
市盈率
18.61
股息率
0.67%
主要交易所
NSE
相关资讯
财务信息
损益表
收入
净收入
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 801.62亿 | 16.51% |
经营支出 | 297.24亿 | 24.54% |
净收入 | 125.53亿 | -15.18% |
净利润率 | 15.66 | -27.20% |
每股收益 | 15.83 | -11.13% |
息税折旧摊销前利润 | 220.20亿 | 8.53% |
有效税率 | 30.01% | — |
资产负债表
总资产
负债总额
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 630.74亿 | -7.15% |
总资产 | 4659.55亿 | 34.27% |
负债总额 | 1566.72亿 | 66.79% |
权益总额 | 3092.83亿 | — |
发行在外的股份 | 8.33亿 | — |
市净率 | 3.28 | — |
资产回报率 | 10.24% | — |
资本回报率 | 13.21% | — |
现金流
现金净变动
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | 125.53亿 | -15.18% |
来自运营的现金 | 93.16亿 | -48.03% |
投资现金 | -190.71亿 | -322.21% |
融资现金 | 161.50亿 | 329.53% |
现金净变动 | 63.72亿 | 1.03% |
自由现金流 | 39.15亿 | -72.47% |
简介
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
CEO
成立时间
1984
员工数量
27,048